We observed that the positive rates of serum SARS-CoV-2 N-Ag in acute COVID-19 patients were higher than those of serum antibodies (including IgM, IgG, IgA and NAb), and there was an opposing result in convalescent patients. The gene discussed is CD79A; the disease is COVID-19.